HSCS (HeartSciences) Current Accrued Expense : $0.42 Mil (As of Jan. 2025)

View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Current Accrued Expense?

HeartSciences's Current Accrued Expense for the quarter that ended in Jan. 2025 was $0.42 Mil.

HeartSciences's quarterly Current Accrued Expense declined from Jul. 2024 ($0.62 Mil) to Oct. 2024 ($0.38 Mil) but then increased from Oct. 2024 ($0.38 Mil) to Jan. 2025 ($0.42 Mil).

HeartSciences's annual Current Accrued Expense declined from Apr. 2022 ($1.05 Mil) to Apr. 2023 ($0.62 Mil) but then increased from Apr. 2023 ($0.62 Mil) to Apr. 2024 ($0.67 Mil).

HeartSciences Current Accrued Expense Historical Data

The historical data trend for HeartSciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Current Accrued Expense Chart

HeartSciences Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Apr24

Current Accrued Expense

0.34

0.29

1.05

0.62

0.67

HeartSciences Quarterly Data
	Apr20	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Current Accrued Expense	Get a 7-Day Free Trial												0.59	0.67	0.62	0.38	0.42

HeartSciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

HeartSciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of HeartSciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

HeartSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website

https://www.heartsciences.com

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Executives

David R. Wells	director	2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent	director	750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz	director, officer: See Remarks	3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson	officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson	director, officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092